> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Plans Survey on Drug Promotion Targeted at Physicians
- URL: https://www.fdaweb.com/fda-plans-survey-on-drug-promotion-targeted-at-physicians/
- Published: 2019-03-08T12:00:00.000Z
- Updated: 2026-09-15T01:11:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143562

FDA is seeking comments on a new information collection related to a proposed “Healthcare Professional Survey of Professional Prescription Drug Promotion.” The survey’s goal is to learn healthcare professionals’ (HCPs) opinions on promotional materials and procedures targeted at HCPs, clinical trial design and knowledge, and FDA approval status. Additionally, the agency says it plans to ask several questions about prescription drug promotion of opioid products.

The [agency says](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-04307.pdf?ref=fdaweb.com) the proposed survey is designed to provide further insights about how professionally targeted prescription drug promotion might influence healthcare professionals’ decision-making processes and practices and how information may be communicated more accurately. The general research questions in the survey are as follows: 

- What methods and/or channels are used to disseminate prescription drug promotional information to healthcare professionals/prescribers?
- How knowledgeable and interested are HCPs in clinical trial data and design and their presence in prescription drug promotion?
- How familiar are HCPs with the FDA approval of prescription drugs and how does this affect prescribing behavior?